InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Zelnick Kaufman Beth. Director active across 1 company, notably CorMedix Inc.. Aggregated, 4 reports have been recorded. Activity tracked since 12 December 2023. The latest transaction was filed on 2 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations